vault backup: 2025-11-28 13:57:22
All checks were successful
Deploy Quartz site to GitHub Pages / build (push) Successful in 1m45s
All checks were successful
Deploy Quartz site to GitHub Pages / build (push) Successful in 1m45s
This commit is contained in:
219
content/Biokemi/Plasmidlabb/Plasmid Lab Part 1 OCR.md
Normal file
219
content/Biokemi/Plasmidlabb/Plasmid Lab Part 1 OCR.md
Normal file
@@ -0,0 +1,219 @@
|
||||
Recombinant DNA technology
|
||||
Lecture by:
|
||||
Anne Wöhr
|
||||
anne.wohr@gu.se
|
||||
|
||||
Recombinant DNA technology
|
||||
Molecular cloning Transformation Selection and
|
||||
Replication
|
||||
Performed during this lab
|
||||
|
||||
Plasmids
|
||||
• Commonly found in bacteria as extra-chromosomal
|
||||
circular dsDNA molecules
|
||||
• Able to self-replicate during cell division
|
||||
• Often carry beneficial genes like antibiotic resistance
|
||||
• Bacteria can share genetic information through
|
||||
plasmid transfer
|
||||
By: Maya Kostman
|
||||
How could this be useful for us?
|
||||
|
||||
Applications of recombinant DNA
|
||||
technologies
|
||||
Khan S., 2016
|
||||
Biopharmaceuticals:
|
||||
Vaccines eg hepatitis B vaccine
|
||||
recombinant proteins eg Insulin (Diabetes), Factor VIII (hemophilia)
|
||||
Genetically modified organisms:
|
||||
Organisms that have been genetically modified to exhibit specific traits eg
|
||||
herbicide-resistant crop plants
|
||||
Gene Therapy:
|
||||
In some genetic disorders, patients lack the functional form of a gene. Gene
|
||||
therapy attempts to provide a normal copy of the gene to the cells of the
|
||||
patient.
|
||||
Gene Analysis:
|
||||
build artificial, recombinant versions of genes that help understand how
|
||||
genes in an organism function
|
||||
|
||||
• Scissors: DNA restriction enzymes (DNA digestion)
|
||||
• Cutting sites: multiple cloning sites (MCS)
|
||||
• Glue: DNA ligase (DNA ligation)
|
||||
• Host: bacterial cells (Transformation)
|
||||
• Environment: LB medium or LB agar plates (Culturing)
|
||||
• Goal: making more identical copies, or expression (making proteins)
|
||||
Toolbox for molecular cloning
|
||||
|
||||
✓ DNA molecule that acts as a vehicle to carry foreign genetic materials
|
||||
into another cell, where it can be replicated or expressed.
|
||||
Vectors
|
||||
Ori (origin of replication):
|
||||
Replication is initiated here, enabling the plasmid to reproduce itself.
|
||||
MCS (multiple cloning site):
|
||||
Short segment of DNA which contains many restriction sites. This
|
||||
allows a piece of DNA to be inserted into that region. The used
|
||||
plasmid contains a BamHI cleavage site in its MCS.
|
||||
AmpR gene:
|
||||
encodes the enzyme beta-Lactamase, which inactivates ampicillin.
|
||||
Cells containing a plasmid vector which expresses AmpR can be
|
||||
selected from those that do not by growth in an ampicillin-containing
|
||||
medium.
|
||||
Lac promoter:
|
||||
binding site of RNA polymerase to initiate expression. IPTG binds
|
||||
and inactivates the LacI repressor protein and thereby enables
|
||||
expression of genes downstream of the promoter.
|
||||
LacZ⍺ gene:
|
||||
encodes the alpha-peptide of the enzyme beta-galactosidase.
|
||||
Functional beta-galactosidase consits of the alpha- and omega-
|
||||
peptide. The used E-coli strain carries the lacZ deletion mutant
|
||||
which contains the omega-peptide but lacks the alpha-peptide. The
|
||||
activity of mutant beta-galactosidase is rescued by the presence of
|
||||
the alpha-peptide present in the plasmid (alpha-complementation).
|
||||
|
||||
Restriction enzymes (Scissors)
|
||||
✓ Sequence-specific DNA endonucleases
|
||||
✓ Recognise and cleave DNA sequences at specific restriction sites
|
||||
✓ Generate “sticky end” or “blunt end”
|
||||
|
||||
Escherichia coli (Host)
|
||||
✓ Model organism in molecular biology
|
||||
✓ Gram negative, rod shaped bacteria
|
||||
✓ Located in lower intestine
|
||||
|
||||
The History of Insulin Production
|
||||
1921: Discovery of insulin
|
||||
1922: Leonard Thompson became the first person with diabetes ever
|
||||
treated through administration of insulin
|
||||
1923: Insulin is commercialized
|
||||
Insulin sales kit, Eli Lilly and Company, 1940s
|
||||
14 cows or 70 pigs to sustain a diabetic
|
||||
patient for 1 year
|
||||
1970: Recombinant DNA technology is
|
||||
developed
|
||||
1982: Recombinant insulin is commercialized
|
||||
|
||||
Production of Insulin
|
||||
Adapted from “From DNA to Beer: Harnessing Nature in Medicine & Industry”
|
||||
|
||||
Purpose of this lab:
|
||||
Determine whether a gene of interest has
|
||||
been successfully cloned into a vector.
|
||||
|
||||
Transformation
|
||||
|
||||
Transformation
|
||||
During the incubation
|
||||
on ice, DNA binds to
|
||||
the surface of the
|
||||
bacterium as a calcium-
|
||||
phosphate-DNA
|
||||
complex
|
||||
Following a sudden
|
||||
increase in
|
||||
temperature, one or
|
||||
more DNA molecules
|
||||
bound to the surface of
|
||||
the cell is taken up by
|
||||
the competent cell
|
||||
|
||||
How can we selectively grow bacteria
|
||||
that have taken up the plasmid?
|
||||
|
||||
Selection pressure
|
||||
✓ ampR gene encodes for beta-lactamase
|
||||
✓ Inactivates ampicilin antibiotics
|
||||
✓ Only cells containing vector DNA will grow
|
||||
in the presence of ampicilin
|
||||
Selection based on antibiotic resistance
|
||||
|
||||
How do we select for bacteria with the plasmids
|
||||
carrying the inserts?
|
||||
By: Maya Kostman
|
||||
|
||||
More detailed info: thermofisher.com
|
||||
LacZ gene naturally found in E. coli, encodes β-galactosidase.
|
||||
We use an E.coli strain that carries the LacZ deletion mutant which
|
||||
contains the omega-peptide but lacks the alpha-peptide and is therefore
|
||||
non-functional. The plasmid we use carries the alpha-peptide, rescuing the
|
||||
function of mutant beta-galactosidase.
|
||||
Blue-white screening
|
||||
|
||||
Lab Schedule
|
||||
• Monday (11/24)
|
||||
Introductory lecture 12:15 – 13:00
|
||||
Lab 13:15 – 14:00 Groups 1-19
|
||||
Lab 14:15 – 15:00 Groups 20-38
|
||||
• Tuesday (11/25)
|
||||
Lab 11:15 – 11:45 Groups 1-19
|
||||
Lab 12:00 – 12:30 Groups 20-38
|
||||
• Wednesday (11/26) Groups 1-19
|
||||
Introductory lecture 8:15 – 9:00
|
||||
Lab 09:15 – 16:00
|
||||
• Thursday (11/27) Groups 20-38
|
||||
Introductory lecture 8:15 – 9:00
|
||||
Lab 9:15 – 16:00
|
||||
Deadline for submitting lab reports: 07/12/2025
|
||||
|
||||
Working in the lab
|
||||
✓ Work in groups of 2 people, stick to your assigned partner
|
||||
✓ Always wear gloves and lab coat to protect you and your samples,
|
||||
wash your hands thoroughly before leaving the lab
|
||||
✓ When using the pipette, check the volume limits (0.1-10μl, 10-200μl,
|
||||
and 100-1000μl)
|
||||
✓ Pipette into the bottom of the tube, do not ”shoot” it (especially when
|
||||
working with very low volumes)
|
||||
|
||||
Transformation of competent cells
|
||||
→ performed during this lab (day 1)
|
||||
✓ 1 tube of plasmids (P) (with/without insert)
|
||||
✓ 1 tube of competent bacteria (C)
|
||||
|
||||
Day 1: Selection of transformed cells
|
||||
→ performed during this lab (day 1)
|
||||
✓ Pick up bacterial colonies (2 white, 2 blue) from plate
|
||||
✓ Grow in LB medium with antibiotics (expand the colony and replicate plasmids)
|
||||
Day 2: Picking & expansion of blue and white
|
||||
colonies
|
||||
→ performed during this lab (day 2)
|
||||
|
||||
Day 1: Materials for Transformation
|
||||
Falcon tube (50ml) LB-agar plate Eppendorf tube
|
||||
Day 1: Spread plate method
|
||||
o Apply light pressure to not tear or stab the agar
|
||||
|
||||
Day 3 - work overview
|
||||
✓ Purify plasmids
|
||||
✓ Restriction enzyme digestion
|
||||
✓ Run on agarose gel
|
||||
✓ Interpret results
|
||||
|
||||
Lab reports
|
||||
✓ Write according to the guidelines on the handout on Canvas
|
||||
✓ One lab report per group (your names and project group number on
|
||||
the cover page)
|
||||
✓ In English
|
||||
✓ Upload your lab reports on CANVAS deadline on 07/12/2025
|
||||
|
||||
Lecture Questions
|
||||
1. Name three applications of molecular cloning.
|
||||
2. What is a plasmid?
|
||||
3. Name the three main steps involved in recombinant DNA technology?
|
||||
4. What is a restriction enzyme?
|
||||
5. What are the bacteria used in your protocol?
|
||||
6. Explain the calcium/phosphate (heat-shock) method and what it is used for.
|
||||
7. How can we selectively grow bacteria that have taken up the plasmid?
|
||||
8. Explain the principle behind blue and white screening and its purpose in this
|
||||
lab.
|
||||
|
||||
References
|
||||
Kehoe A (1989). "The story of biosynthetic human insulin". In Sikdar SK, Bier M, Todd PW (eds.).
|
||||
Frontiers in Bioprocesssing. Boca Raton, FL: CRC Press. ISBN 978-0-8493-5839-5.
|
||||
https://www.sigmaaldrich.com/SE/en/technical-documents/technical-article/genomics/cloning-and
|
||||
expression/blue-white-screening
|
||||
https://www.nlm.nih.gov/exhibition/fromdnatobeer/exhibition-interactive/recombinant
|
||||
DNA/recombinant-dna-technology-alternative.html
|
||||
Khan, S., Ullah, M. W., Siddique, R., Nabi, G., Manan, S., Yousaf, M., & Hou, H. (2016). Role of
|
||||
Recombinant DNA Technology to Improve Life. International journal of genomics, 2016, 2405954.
|
||||
https://doi.org/10.1155/2016/2405954
|
||||
https://www.thermofisher.com/se/en/home/life-science/cloning/cloning-learning-center/invitrogen
|
||||
school-of-molecular-biology/molecular-cloning/cloning/traditional-cloning-basics.html
|
||||
|
||||
Reference in New Issue
Block a user